Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves

European Heart Journal

Volumn 37, Issue 28, 2016, Pages 2263-2271

  Pache, Gregor ^a   Schoechlin, Simon ^b   Blanke, Philipp ^c   Dorfs, Stephan ^b   Jander, Nikolaus ^b   Arepalli, Chesnal D ^c   Gick, Michael ^b   Buettner, Heinz Joachim ^b   Leipsic, Jonathon ^c   Langer, Mathias ^a   Neumann, Franz Josef ^b   Ruile, Philipp ^b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Computed tomography; Leaflet thickening; Sapien 3; TAVI; Transcatheter heart valve

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PHENPROCOUMON;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BALLOON EXPANDABLE TRANSCATHETER AORTIC HEART VALVE PROSTHESIS; CARDIAC PATIENT; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; DISEASE ASSOCIATION; ELECTROCARDIOGRAM; EVALUATION STUDY; FEMALE; FOLLOW UP; HEART VALVE PROSTHESIS; HUMAN; HYPO ATTENUATED LEAFLET THICKENING; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRESSURE GRADIENT; PRIORITY JOURNAL; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVULAR HEART DISEASE; AORTIC VALVE; HEART VALVE REPLACEMENT; TREATMENT OUTCOME; VERY ELDERLY;

AGED, 80 AND OVER; AORTIC VALVE; FEMALE; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 84991660312     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehv526     Document Type: Article

References (34)

1. Pache G, Blanke P, Zeh W, Jander N. Cusp thrombosis after transcatheter aortic valve replacement detected by computed tomography and echocardiography. Eur Heart J 2013;34:3546
2. Leetmaa TH, Poulsen SH, Nö rgaard BL, Klaaborg K-E, Terp K, Hoyer S, Christiansen EH, Andersen HR. Two cases of thrombotic stenosis in SAPIEN XT valves after transapical implantation. EuroIntervention 2014;10:270
3. Lancellotti P, Radermecker MA, Weisz SH, Legrand V. Subacute transcatheter CoreValve thrombotic obstruction. Circ Cardiovasc Interv 2013;6:e32-e33
4. Cota L, Stabile E, Agrusta M, Sorropago G, Pucciarelli A, Ambrosini V, Mottola G, Esposito G, Rubino P. Bioprostheses 'thrombosis' after transcatheter aortic valve replacement. J Am Coll Cardiol 2013;61:789-791
5. Latib A, Messika-Zeitoun D, Maisano F, Himbert D, Brochet E, Alfieri O, Colombo A, Vahanian A. Reversible Edwards Sapien XT dysfunction due to prosthesis thrombosis presenting as early structural deterioration. J Am Coll Cardiol 2013;61:787-789
6. Trepels T, Martens S, Doss M, Fichtlscherer S, Schachinger V. Thrombotic restenosis after minimally invasive implantation of aortic valve stent. Circulation 2009;120: e23-e24
7. Cordoba-Soriano JG, Puri R, Amat-Santos I, Ribeiro HB, Jawah OA, Del Trigo M, Paradis JM, Dumont E, Urena M, Rodes-Cabau J. Valve thrombosis following transcatheter aortic valve implantation: a systematic review. Rev Esp Cardiol Engl Ed 2015; 68:198-204
8. Jander N, Pache G, Henschke S, Minners J. Diagnosis of obstructive thrombosis in a porcine bioprosthesis in the aortic position by contrast-enhanced ECG-gated computer tomography. Eur Heart J 2013;34:1357
9. Merie C, Køber L, Olsen PS, Andersson C, Gislason G, Jensen JS, Torp-Pedersen C. Association of warfarin therapy duration after bioprosthetic aortic valve replacement with risk of mortality, thromboembolic complications, and bleeding. JAMA 2012;308:2118-2125
10. Mylotte D, Andalib A, Theriault-Lauzier P, Dorfmeister M, Girgis M, Alharbi W, Chetrit M, Galatas C, Mamane S, Sebag I, Buithieu J, Bilodeau L, de Varennes B, Lachapelle K, Lange R, Martucci G, Virmani R, Piazza N. Transcatheter heart valve failure: a systematic review. Eur Heart J 2015;36:1306-1327
11. Jander N, Kienzle R-P, Kayser G, Neumann F-J, Gohlke-Baerwolf C, Minners J. Usefulness of phenprocoumon for the treatment of obstructing thrombus in bioprostheses in the aortic valve position. Am J Cardiol 2012;109:257-262
12. Blanke P, Schoepf UJ, Leipsic JA. CT in transcatheter aortic valve replacement. Radiology 2013;269:650-669
13. Leetmaa T, Hansson NC, Leipsic J, Jensen K, Poulsen SH, Andersen HR, Jensen JM, Webb J, Blanke P, Tang M, Nørgaard BL. Early aortic transcatheter heart valve thrombosis: diagnostic value of contrast-enhanced multidetector computed tomography. Circ Cardiovasc Interv 2015;8:doi: 10.1161/CIRCINTERVENTIONS. 114.001596
14. Binder RK, Rodes-Cabau J, Wood DA, Mok M, Leipsic J, De Larochelliere R, Toggweiler S, Dumont E, Freeman M, Willson AB,Webb JG. Transcatheter aortic valve replacement with the SAPIEN 3. JACC Cardiovasc Interv 2013;6:293-300
15. Ye J, Cheung A, Lichtenstein SV, Carere RG, Thompson CR, Pasupati S,Webb JG. Transapical aortic valve implantation in humans. J Thorac Cardiovasc Surg 2006;131: 1194-1196
16. Webb JG. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-850
17. Blanke P, Siepe M, Reinö hl J, Zehender M, Beyersdorf F, Schlensak C, Langer M, Pache G. Assessment of aortic annulus dimensions for Edwards SAPIEN Transapical Heart Valve implantation by computed tomography: calculating average diameter using a virtual ring method. Eur J Cardiothorac Surg 2010; 38:750-758
18. Zoghbi WA, Chambers JB, Dumesnil JG, Foster E, Gottdiener JS, Grayburn PA, Khandheria BK, Levine RA, Marx GR, Miller FA Jr, Nakatani S, Quinones MA, Rakowski H, Rodriguez LL, Swaminathan M, Waggoner AD, Weissman NJ, Zabalgoitia M. Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr 2009;22:975-1014
19. Dewilde WJ, Oirbans T, Verheugt FW, Kelder JC, De Smet BJ, Herrman J-P, Adriaenssens T, Vrolix M, Heestermans AA, Vis MM, Tijsen JG, van 't Hof AW, Berg JM. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an openlabel, randomised, controlled trial. The Lancet 2013;381:1107-1115
20. Latib A, Naganuma T, Abdel-Wahab M, Danenberg H, Cota L, Barbanti M, Baumgartner H, Finkelstein A, Legrand V, de Lezo JS, Kefer J, Messika-Zeitoun D, Richardt G, Stabile E, Kaleschke G, Vahanian A, Laborde J-C, Leon MB, Webb JG, Panoulas VF, Maisano F, Alfieri O, Colombo A. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv 2015;8. http://circinterventions.ahajournals.org/content/8/4/e001779. abstract
21. Huck V, Schneider MF, Gorzelanny C, Schneider SW. The various states of von Willebrand factor and their function in physiology and pathophysiology. Thromb Haemost 2014;111:598-609
22. Hochholzer W, Trenk D, Fromm MF, Valina CM, Stratz C, Bestehorn H-P, Büttner HJ, Neumann F-J. Impact of cytochrome P450 2C19 loss-of-function polymorphism and of major demographic characteristics on residual platelet function after loading and maintenance treatment with clopidogrel in patients undergoing elective coronary stent placement. J Am Coll Cardiol 2010;55:2427-2434
23. Holmes DR, Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, Calhoon JH, Carabello BA, Desai MY, Edwards FH, Francis GS, Gardner TJ, Kappetein AP, Linderbaum JA, Mukherjee C, Mukherjee D, Otto CM, Ruiz CE, Sacco RL, Smith D, Thomas JD, Harrington RA, Bhatt DL, Ferrari VA, Fisher JD, Garcia MJ, Gardner TJ, Gentile F, Gilson MF, Hernandez AF, Jacobs AK, Kaul S, LinderbaumJA, Moliterno DJ,Weitz HH. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Thorac Cardiovasc Surg 2012;144:e29-e84
24. Authors/Task Force Members, Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schafers H-J, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Popescu BA, Von Segesser L, Badano LP, Bunc M, Claeys MJ, Drinkovic N, Filippatos G, Habib G, Kappetein AP, Kassab R, Lip GYH, Moat N, Nickenig G, Otto CM, Pepper J, Piazza N, Pieper PG, Rosenhek R, Shuka N, Schwammenthal E, Schwitter J, Mas PT, Trindade PT, Walther T. Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur J Cardiothorac Surg 2012;42:S1-S44
25. Stabile E, Pucciarelli A, Cota L, Sorropago G, Tesorio T, Salemme L, Popusoi G, Ambrosini V, Cioppa A, Agrusta M, Catapano D, Moscariello C, Trimarco B, Esposito G, Rubino P. SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation. Int J Cardiol 2014;174:624-627
26. Ussia GP, Scarabelli M, Mule M, Barbanti M, Sarkar K, Cammalleri V, Imme S, Aruta P, Pistritto AM, Gulino S, DesteW, Capodanno D, Tamburino C. Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation. Am J Cardiol 2011;108:1772-1776
27. Butnaru A, Shaheen J, Tzivoni D, Tauber R, Bitran D, Silberman S. Diagnosis and treatment of early bioprosthetic malfunction in the mitral valve position due to thrombus formation. Am J Cardiol 2013;112:1439-1444
28. Pislaru SV, Hussain I, Pellikka PA, Maleszewski JJ, Hanna RD, Schaff HV, Connolly HM. Misconceptions, diagnostic challenges and treatment opportunities in bioprosthetic valve thrombosis: lessons from a case series. Eur J Cardiothorac Surg 2014;47:725-732
29. Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C, Nalysnyk L. Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis. CHEST J 2004;126:1938-1945
30. Anselmino M, Andria A. Embolization from biological prosthetic aortic root. Eur J Echocardiogr 2006;7:228-229
31. Pozsonyi Z, Lengyel M. Successful thrombolysis of late, non-obstructive mitral bioprosthetic valve thrombosis: case report and review of the literature. J Heart Valve Dis 2011;20:526-530
32. Roudaut R, Serri K, Lafitte S. Thrombosis of prosthetic heart valves: diagnosis and therapeutic considerations. Heart 2007;93:137-142
33. Webb J, Gerosa G, Lefevre T, Leipsic J, Spence M, Thomas M, Thielmann M, Treede H, Wendler O, Walther T. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J AmColl Cardiol 2014;64:2235-2243
34. Murray M-I, Geis N, Pleger ST, Kallenbach K, Katus HA, Bekeredjian R, Chorianopoulos E. First experience with the new generation Edwards Sapien 3 aortic bioprosthesis: procedural results and short term outcome: first experience with the SAPIEN 3 TAVR device. J Intervent Cardiol 2015;28: 109-116